Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/78906
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWhite, D.-
dc.contributor.authorEadie, L.-
dc.contributor.authorSaunders, V.-
dc.contributor.authorHiwase, D.-
dc.contributor.authorHughes, T.-
dc.date.issued2013-
dc.identifier.citationLeukemia, 2013; 27(5):1201-1204-
dc.identifier.issn0887-6924-
dc.identifier.issn1476-5551-
dc.identifier.urihttp://hdl.handle.net/2440/78906-
dc.description.statementofresponsibilityDL White, LN Eadie, VA Saunders, DK Hiwase, and TP Hughes-
dc.language.isoen-
dc.publisherNature Publishing Group-
dc.rights© 2013 Macmillan Publishers Limited-
dc.source.urihttp://dx.doi.org/10.1038/leu.2012.295-
dc.subjectK562 Cells-
dc.subjectHumans-
dc.subjectBenzamides-
dc.subjectPiperazines-
dc.subjectPyrimidines-
dc.subjectProtein Kinase Inhibitors-
dc.subjectDrug Interactions-
dc.subjectLeukemia, Myelogenous, Chronic, BCR-ABL Positive-
dc.subjectProton Pump Inhibitors-
dc.subjectImatinib Mesylate-
dc.titleProton pump inhibitors significantly increase the intracellular concentration of nilotinib, but not imatinib in target CML cells-
dc.typeJournal article-
dc.identifier.doi10.1038/leu.2012.295-
pubs.publication-statusPublished-
dc.identifier.orcidWhite, D. [0000-0003-4844-333X]-
dc.identifier.orcidEadie, L. [0000-0003-1912-7602]-
dc.identifier.orcidHiwase, D. [0000-0002-6666-3056]-
dc.identifier.orcidHughes, T. [0000-0002-0910-3730] [0000-0002-7990-4509]-
Appears in Collections:Aurora harvest 4
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.